Abstract
This chapter explains in detail, the role of nitric oxide pathway and its players, in health and disease. These players may be endogenous (activators or inhibitors) or exogenous (donors or inhibitors) in nature. Nitric oxide donors are clinically important since they have a major share to play in the management of several pathophysiological disorders. The chapter also throws light on the various vasoactive peptides that may be vasoconstrictors or vasodilators (or sometimes, mixed). Finally, the chapter also explains the role of purines in the management of various microbial disorders and cancers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Bibliography
Bilezikian JP, Raisz LG, Martin JT (eds) (2008) Principles of bone biology, 3rd edn. Elsevier, Amsterdam, pp 285–318
Carroll GR (ed) (2007) Endocrine system. Elsevier, Amsterdam, pp 157–176
Chandran S, Sridhar N, Veeranjaneyulu A (1998) Nitric oxide: concepts, current perspectives and future therapeutic implications. Indian J Pharmacol 30:351–366
Despande SR, Satyanarayana K, Rao MNA, Pai KV (2012) Nitric oxide modulators: an emerging class of medicinal agents. Indian J Pharm Sci 74(6):487–497
Dinesh S, Shikha G, Bhavana G, Nidhi S, Dileep S (2012) Biological activities of purine analogues: a review. JPSI 1(2):29–34
Gribble FM, Reimann F, Robert GP (2018) Gastrointestinal hormones. In: Said HM (ed) Physiology of gastrointestinal tract, 2nd edn. Elsevier, Amsterdam, pp 31–70
Huerta S, Chilka S, Bonavida B (2008) Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol 33(5):909–927
Kastin AJ (ed) (2013) Somatostatin, 2nd edn. Elsevier, Amsterdam, pp 1320–1329
Kusserow H, Unger T (2004) Vasoactive peptides, their receptors and drug development. Basic Clin Pharmacol Toxicol 94(1):5–12
Said SI (1983) Vasoactive peptides. State-of-the-art review. Hypertension 5(2 Pt 2):I17–I26
Somerville RL (2001) Purine. In: Brenner S, Miller JH (eds) Encyclopedia of genetics. Elsevier, Amsterdam, p 1585
Treschan TA, Peters J (2006) The vasopressin system: physiology and clinical strategies. Anesthesiology 105(3):599–612
Vrachnis N, Malamas MF, Sifakis S, Deligeoroglou E, Iliodromiti Z (2011) The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents. Int J Endocrinol 2011:350546
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Paulose, R.M. (2021). Nitric Oxide, Vasoactive Peptides, and Purines. In: Paul, A., Anandabaskar, N., Mathaiyan, J., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-33-6009-9_22
Download citation
DOI: https://doi.org/10.1007/978-981-33-6009-9_22
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6008-2
Online ISBN: 978-981-33-6009-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)